메뉴 건너뛰기




Volumn 4, Issue 6, 2015, Pages 360-366

Efficacy profile of intracameral amphotericin B. the often forgotten step

Author keywords

Anterior Chamber; Corneal Blindness; Hypopyon; Intracameral Amphotericin B; Keratomycosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; EYE DROPS; FLUCONAZOLE; NATAMYCIN;

EID: 84988851416     PISSN: None     EISSN: 21620989     Source Type: Journal    
DOI: 10.1097/APO.0000000000000107     Document Type: Article
Times cited : (16)

References (37)
  • 3
    • 0026182962 scopus 로고
    • Common causes of blindness: A pilot survey in Jaipur, Rajasthan
    • Rekhi GS, Kulshreshtha OP. Common causes of blindness: A pilot survey in Jaipur, Rajasthan. Indian J Ophthalmol. 1991;39: 108-111.
    • (1991) Indian J Ophthalmol , vol.39 , pp. 108-111
    • Rekhi, G.S.1    Kulshreshtha, O.P.2
  • 4
    • 77951162743 scopus 로고    scopus 로고
    • Mycotic keratitis in India: A five-year retrospective study
    • Tilak R, Singh A, Maurya OP, et al. Mycotic keratitis in India: A five-year retrospective study. J Infect Dev Ctries. 2010;4: 171-174.
    • (2010) J Infect Dev Ctries , vol.4 , pp. 171-174
    • Tilak, R.1    Singh, A.2    Maurya, O.P.3
  • 6
    • 4243592392 scopus 로고    scopus 로고
    • Antifungal agents. In: Tabbara KF Hyndiuk RA, eds. Infections of the Eye. Boston, MA, Little Brown
    • Yee RW, Boone DE, Rinaldi MG. Antifungal agents. In: Tabbara KF, Hyndiuk RA, eds. Infections of the Eye. Boston, MA: Little Brown; 1996:249-267.
    • (1996) , pp. 249-267
    • Yee, R.W.1    Boone, D.E.2    Rinaldi, M.G.3
  • 7
    • 0035738546 scopus 로고    scopus 로고
    • Intracameral amphotericin B Initial experience in severe keratomycosis
    • Kaushik S, Ram J, Brar GS, et al. Intracameral amphotericin B. Initial experience in severe keratomycosis. Cornea. 2001;20: 715-719.
    • (2001) Cornea , vol.20 , pp. 715-719
    • Kaushik, S.1    Ram, J.2    Brar, G.S.3
  • 8
    • 0036784873 scopus 로고    scopus 로고
    • Intracameral amphotericin B injection in the management of deep keratomycosis
    • Kuriakose T, Kothari M, Paul P, et al. Intracameral amphotericin B injection in the management of deep keratomycosis. Cornea. 2002;21:653-656.
    • (2002) Cornea , vol.21 , pp. 653-656
    • Kuriakose, T.1    Kothari, M.2    Paul, P.3
  • 9
    • 34247584001 scopus 로고    scopus 로고
    • Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis
    • Yilmaz S. Efficacy of intracameral amphotericin B injection in the management of refractory keratomycosis and endophthalmitis. Cornea. 2007;26:398-402.
    • (2007) Cornea , vol.26 , pp. 398-402
    • Yilmaz, S.1
  • 10
    • 34547692873 scopus 로고    scopus 로고
    • Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis
    • Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of intracameral amphotericin B injection in the treatment of fungal keratitis. Cornea. 2007;26:814-818.
    • (2007) Cornea , vol.26 , pp. 814-818
    • Yoon, K.C.1    Jeong, I.Y.2    Im, S.K.3
  • 11
    • 84894642788 scopus 로고    scopus 로고
    • Therapeutic efficacy of ICAMB in keratomycosis
    • Shao Y, Yao Y, Pei CG, et al. Therapeutic efficacy of ICAMB in keratomycosis. Int J Ophthalmol. 2010;3:257-260.
    • (2010) Int J Ophthalmol , vol.3 , pp. 257-260
    • Shao, Y.1    Yao, Y.2    Pei, C.G.3
  • 13
    • 0032474214 scopus 로고    scopus 로고
    • Is current eye-care-policy focus almost exclusively on cataract adequate to deal with blindness in India
    • Dandona L, Dandona R, Naduvilath T, et al. Is current eye-care-policy focus almost exclusively on cataract adequate to deal with blindness in India? Lancet. 1998;351:1312-1316.
    • (1998) Lancet , vol.351 , pp. 1312-1316
    • Dandona, L.1    Dandona, R.2    Naduvilath, T.3
  • 16
    • 0026067340 scopus 로고
    • Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal
    • Upadhyay MP, Karmacharya PC, Koirala S. Epidemiologic characteristics, predisposing factors, and etiologic diagnosis of corneal ulceration in Nepal. Am J Ophthalmol. 1991;111:92-99.
    • (1991) Am J Ophthalmol , vol.111 , pp. 92-99
    • Upadhyay, M.P.1    Karmacharya, P.C.2    Koirala, S.3
  • 17
    • 74949104619 scopus 로고    scopus 로고
    • Spectrum of fungal keratitis in central China
    • Wang L, Sun S, Jing Y, et al. Spectrum of fungal keratitis in central China. Clin Exp Ophthalmol. 2009;37:763-771.
    • (2009) Clin Exp Ophthalmol , vol.37 , pp. 763-771
    • Wang, L.1    Sun, S.2    Jing, Y.3
  • 18
    • 67650650955 scopus 로고    scopus 로고
    • Fungal keratitis in the United Kingdom 2003-2005
    • Tuft SJ, Tullo AB. Fungal keratitis in the United Kingdom 2003-2005. Eye (Lond). 2009;23:1308-1313.
    • (2009) Eye (Lond) , vol.23 , pp. 1308-1313
    • Tuft, S.J.1    Tullo, A.B.2
  • 20
    • 0018622624 scopus 로고
    • Immunopotentiating effect of amphotericin B
    • Shirley SF, Little JR. Immunopotentiating effect of amphotericin B. J Immunol. 1979;123:2878-2882.
    • (1979) J Immunol , vol.123 , pp. 2878-2882
    • Shirley, S.F.1    Little, J.R.2
  • 22
    • 0017100435 scopus 로고
    • Treatment of keratomycosis with amphotericin B 0.15%
    • Wood TO, Williford W. Treatment of keratomycosis with amphotericin B 0.15%. Am J Ophthalmol. 1976;81:847-848.
    • (1976) Am J Ophthalmol , vol.81 , pp. 847-848
    • Wood, T.O.1    Williford, W.2
  • 23
    • 0026508537 scopus 로고
    • Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicansYinduced keratomycosis in rabbits
    • Pleyer U, Legmann A, Mondino BJ, et al. Use of collagen shields containing amphotericin B in the treatment of experimental Candida albicansYinduced keratomycosis in rabbits. Am J Ophthalmol. 1992;113:303-307.
    • (1992) Am J Ophthalmol , vol.113 , pp. 303-307
    • Pleyer, U.1    Legmann, A.2    Mondino, B.J.3
  • 25
    • 0030729244 scopus 로고    scopus 로고
    • Treatment of fungal corneal ulcer with amphotericin B ointment
    • Hirose H, Terasaki H, Awaya S, et al. Treatment of fungal corneal ulcer with amphotericin B ointment. Am J Ophthalmol. 1997;124:836-838.
    • (1997) Am J Ophthalmol , vol.124 , pp. 836-838
    • Hirose, H.1    Terasaki, H.2    Awaya, S.3
  • 26
    • 0022885407 scopus 로고
    • Bioavailability and penetration of topical amphotericin B in the anterior chamber of the rabbit eye
    • O'Day DM, Head WS, Robinson RD, et al. Bioavailability and penetration of topical amphotericin B in the anterior chamber of the rabbit eye. J Ocul Pharmacol. 1986;2:371-378.
    • (1986) J Ocul Pharmacol , vol.2 , pp. 371-378
    • O'Day, D.M.1    Head, W.S.2    Robinson, R.D.3
  • 27
    • 0001968472 scopus 로고    scopus 로고
    • Fungal keratitis
    • Pepose JS Holland GN Wilhelmus KR eds. St Louis MO Mosby Year-Book
    • O'Day DM. Fungal keratitis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St Louis, MO: Mosby Year-Book; 1996:1048-1061.
    • (1996) Ocular Infection and Immunity , pp. 1048-1061
    • O'Day, D.M.1
  • 28
    • 0027524496 scopus 로고
    • Qualitative evaluation of the pharmacokinetics of subconjunctival injection of antifungal agents in rabbits
    • Klippenstein K, Robinson RD, Williams TE, et al. Qualitative evaluation of the pharmacokinetics of subconjunctival injection of antifungal agents in rabbits. Cornea. 1995;12:512-515.
    • (1995) Cornea , vol.12 , pp. 512-515
    • Klippenstein, K.1    Robinson, R.D.2    Williams, T.E.3
  • 29
    • 0001418892 scopus 로고
    • Some intraocular and conjunctival effects of amphotericin B in man and the rabbit
    • Foster JBT, Almeda E, Littman ML, et al. Some intraocular and conjunctival effects of amphotericin B in man and the rabbit. Arch Ophthalmol. 1958;60:555-564.
    • (1958) Arch Ophthalmol , vol.60 , pp. 555-564
    • Jbt, F.1    Almeda, E.2    Littman, M.L.3
  • 30
    • 85008400725 scopus 로고    scopus 로고
    • Waring P, eds. Corneal Disorders. Clinical Diagnosis and Management. Philadelphia, PA: WB, Saunders
    • O'Day DM. Antifungal agents. In: Leibowitz H, Waring P, eds. Corneal Disorders. Clinical Diagnosis and Management. Philadelphia, PA: WB Saunders; 1998:608-610.
    • (1998) Antifungal Agents. Leibowitz H , pp. 608-610
    • O'Day, D.M.1
  • 31
  • 32
    • 0022621253 scopus 로고
    • Miconazole and ketocanozole as a satisfactory first-line treatment for keratomycosis
    • Fitzsimons R, Peters AL. Miconazole and ketocanozole as a satisfactory first-line treatment for keratomycosis. Am J Ophthalmol. 1986;101:605-608.
    • (1986) Am J Ophthalmol , vol.101 , pp. 605-608
    • Fitzsimons, R.1    Peters, A.L.2
  • 33
    • 0020691950 scopus 로고
    • Oral ketoconazole therapy for keratomycosis
    • Ishibashi Y. Oral ketoconazole therapy for keratomycosis. Am J Ophthalmol. 1983;95:342-345.
    • (1983) Am J Ophthalmol , vol.95 , pp. 342-345
    • Ishibashi, Y.1
  • 34
    • 0023019184 scopus 로고
    • Corneal penetration of topical amphotericin B and natamycin
    • O'Day DM, Head WS, Robinson RD, et al. Corneal penetration of topical amphotericin B and natamycin. Curr Eye Res. 1986;5:877-882.
    • (1986) Curr Eye Res , vol.5 , pp. 877-882
    • O'Day, D.M.1    Head, W.S.2    Robinson, R.D.3
  • 35
    • 0024246537 scopus 로고
    • Pharmacological management of keratomycosis
    • Johns KJ, O'Day DM. Pharmacological management of keratomycosis. Surv Ophthalmol. 1988;33:178-188.
    • (1988) Surv Ophthalmol , vol.33 , pp. 178-188
    • Johns, K.J.1    O'Day, D.M.2
  • 36
    • 0023491375 scopus 로고
    • Selection of appropriate antifungal therapy
    • O'Day DM. Selection of appropriate antifungal therapy. Cornea. 1987;6:238-245.
    • (1987) Cornea , vol.6 , pp. 238-245
    • O'Day, D.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.